Dynavax to Present on Inhaled TLR9 Agonist DV281 at the AACR Annual Meeting 2019

Ads

You May Also Like

Inovio Pharmaceuticals Reports 2016 Fourth Quarter and Year End Financial Results

PLYMOUTH MEETING, Pa., March 15, 2017 (GLOBE NEWSWIRE) -- Inovio Pharmaceuticals, Inc. (NASDAQ:INO) today ...

pSivida Corp. Provides Company Update and Reports Second Quarter FY 2016 Results

WATERTOWN, Mass., Feb. 08, 2016 (GLOBE NEWSWIRE) -- pSivida Corp. (NASDAQ:PSDV), (ASX:PVA),  a leader ...

VBI Vaccines to Present New Preclinical Data for its GBM Immunotherapy, VBI-1901, at SITC 2017

New data confirms use of intradermal delivery of eVLPs may be a potent “off-the-shelf” immunotherapy ...